Merck to present HPV vaccine data showing 14-18 year efficacy

March 17, 2026 6:50 AM

Merck (NYSE: MRK) announced it will present clinical data on the long-term effectiveness of its HPV vaccines GARDASIL 9 and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found